Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.

Choi, Mira; Bachmann, Friederike; Wu, Kaiyin; Lachmann, Nils; Schmidt, Danilo; Brakemeier, Susanne; Duerr, Michael; Kahl, Andreas; Eckardt, Kai-Uwe; Budde, Klemens; Nickel, Peter

Choi, Mira; Bachmann, Friederike; Wu, Kaiyin; Lachmann, Nils; Schmidt, Danilo; Brakemeier, Susanne; Duerr, Michael; Kahl, Andreas; Eckardt, Kai-Uwe; Budde, Klemens; Nickel, Peter.

Afiliação

Choi M; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany. mira.choi@charite.de.
Bachmann F; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Wu K; Department of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Lachmann N; Tissue Typing Laboratory, Charité Universitätsmedizin Berlin, Berlin, Germany.
Schmidt D; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Brakemeier S; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Duerr M; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Kahl A; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Budde K; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Nickel P; Department of Nephrology and Medical Intensive Care, Charité Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

BMC Nephrol ; 21(1): 354, 2020 08 20.

Article em En | MEDLINE | ID: mdl-32819287

Assuntos

Abatacepte/uso terapêutico; Inibidores de Calcineurina/efeitos adversos; Substituição de Medicamentos; Rejeição de Enxerto/prevenção & controle; Sobrevivência de Enxerto; Imunossupressores/uso terapêutico; Transplante de Rim; Insuficiência Renal/induzido quimicamente; Adulto; Idoso; Feminino; Taxa de Filtração Glomerular; Humanos; Inflamação/patologia; Quimioterapia de Manutenção; Masculino; Microvasos/patologia; Pessoa de Meia-Idade; Transplante de Pâncreas; Insuficiência Renal/metabolismo; Insuficiência Renal/patologia; Fatores de Risco; Transplantes/patologia

Palavras-chave

Allograft failure; Belatacept; Calcineurin inhibitor toxicity; Kidney transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Insuficiência Renal / Substituição de Medicamentos / Inibidores de Calcineurina / Abatacepte / Rejeição de Enxerto / Sobrevivência de Enxerto / Imunossupressores Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google